Julie M. Vose
- Pathology and Forensic Medicine top 0.01%
- Lymphoma Diagnosis and Treatment 332
- Genetics top 0.02%
- Chronic Lymphocytic Leukemia Research 160
- Oncology top 0.05%
- Viral-associated cancers and disorders 86
- CAR-T cell therapy research 47
- Neurology top 0.1%
- CNS Lymphoma Diagnosis and Treatment 46
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation 46
-
- Lung Cancer Treatments and Mutations 47
-
- T-cell and Retrovirus Studies 35
- Co-authors
- Jamés O. ArmitagePhilip J. BiermanDennis D. WeisenburgerJoseph M. ConnorsRichard I. FisherRandy D. GascoyneRichard T. HoppeSandra J. Horning
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Clinical Oncology (75 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
Julie M. Vose
447 papers receiving 24.8k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Pathology and Forensic Medicine 19.0k
- Genetics 6.9k
- Oncology 13.1k
- Neurology 4.5k
- Hematology 3.2k
Countries citing papers authored by Julie M. Vose
This map shows the geographic impact of Julie M. Vose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie M. Vose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie M. Vose more than expected).
Fields of papers citing papers by Julie M. Vose
This network shows the impact of papers produced by Julie M. Vose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie M. Vose. The network helps show where Julie M. Vose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie M. Vose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2021 | 1 | |
| 3 | 2021 | 1 | |
| 4 | 2019 | 64 | |
| 5 | 2017 | 230 | |
| 6 | 2015 | 66 | |
| 7 | 2015 | 73 | |
| 8 | 2015 | 43 | |
| 9 | 2014 | 20 | |
| 10 | 2013 | 25 | |
| 11 | 2008 | 74 | |
| 12 | 2008 | 300 | |
| 13 | 2006 | 0 | |
| 14 | 2006 | 79 | |
| 15 | Allogeneic transplantation following failure of autologous transplantation for lymphoma. | 1998 | 3 |
| 16 | 1995 | 5 | |
| 17 | 1995 | 5 | |
| 18 | 1994 | 11 | |
| 19 | 1993 | 4 | |
| 20 | 1993 | 79 |
About Julie M. Vose
Julie M. Vose is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 460 papers that have together received 25.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (332 papers), Chronic Lymphocytic Leukemia Research (160 papers), Viral-associated cancers and disorders (86 papers), Lung Cancer Treatments and Mutations (47 papers), CAR-T cell therapy research (47 papers), CNS Lymphoma Diagnosis and Treatment (46 papers), Hematopoietic Stem Cell Transplantation (46 papers) and T-cell and Retrovirus Studies (35 papers). The work is most often cited by research in Pathology and Forensic Medicine (19.0k citations), Genetics (6.9k citations) and Oncology (13.1k citations). Julie M. Vose has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Jamés O. Armitage, Philip J. Bierman, Dennis D. Weisenburger, Joseph M. Connors, Richard I. Fisher, Randy D. Gascoyne, Richard T. Hoppe, Sandra J. Horning, Anton Hagenbeek and Nancy L. Harris. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.